Weiwei Sha

625 total citations
27 papers, 500 citations indexed

About

Weiwei Sha is a scholar working on Cellular and Molecular Neuroscience, Cognitive Neuroscience and Developmental Neuroscience. According to data from OpenAlex, Weiwei Sha has authored 27 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cellular and Molecular Neuroscience, 8 papers in Cognitive Neuroscience and 7 papers in Developmental Neuroscience. Recurrent topics in Weiwei Sha's work include Nerve injury and regeneration (8 papers), Neurogenesis and neuroplasticity mechanisms (7 papers) and Autism Spectrum Disorder Research (6 papers). Weiwei Sha is often cited by papers focused on Nerve injury and regeneration (8 papers), Neurogenesis and neuroplasticity mechanisms (7 papers) and Autism Spectrum Disorder Research (6 papers). Weiwei Sha collaborates with scholars based in China, Canada and United Kingdom. Weiwei Sha's co-authors include Xiaobin Zhang, Zhijun Zhang, Honghui Zhou, Xiaowei Tang, Guangjun Xi, Chunming Xie, Yumei Zhang, Zhijun Zhang, Gavin P. Reynolds and Gang Hou and has published in prestigious journals such as Journal of Affective Disorders, Schizophrenia Bulletin and Psychiatry Research.

In The Last Decade

Weiwei Sha

26 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiwei Sha China 14 168 135 123 105 104 27 500
Wendy Shelly United States 7 179 1.1× 106 0.8× 152 1.2× 80 0.8× 83 0.8× 12 627
Alexander Jatzko Germany 11 135 0.8× 79 0.6× 123 1.0× 58 0.6× 137 1.3× 21 511
Stephanie E. Daws United States 9 224 1.3× 172 1.3× 80 0.7× 153 1.5× 296 2.8× 11 679
Chiyo Shibasaki Japan 12 88 0.5× 148 1.1× 99 0.8× 116 1.1× 72 0.7× 19 429
Anilkumar Pillai United States 11 240 1.4× 69 0.5× 163 1.3× 66 0.6× 153 1.5× 16 640
Eiliv Brenner Norway 13 178 1.1× 151 1.1× 78 0.6× 83 0.8× 100 1.0× 16 456
Matthew Williams United Kingdom 8 143 0.9× 86 0.6× 87 0.7× 210 2.0× 237 2.3× 14 617
Silvia Diekmann Germany 11 241 1.4× 112 0.8× 152 1.2× 52 0.5× 151 1.5× 11 545
Daniel T. Ohm United States 13 137 0.8× 98 0.7× 146 1.2× 60 0.6× 66 0.6× 22 505

Countries citing papers authored by Weiwei Sha

Since Specialization
Citations

This map shows the geographic impact of Weiwei Sha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Sha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Sha more than expected).

Fields of papers citing papers by Weiwei Sha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei Sha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Sha. The network helps show where Weiwei Sha may publish in the future.

Co-authorship network of co-authors of Weiwei Sha

This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei Sha. A scholar is included among the top collaborators of Weiwei Sha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei Sha. Weiwei Sha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sha, Weiwei, et al.. (2021). Shaping the Microglia in Retinal Degenerative Diseases Using Stem Cell Therapy: Practice and Prospects. Frontiers in Cell and Developmental Biology. 9. 741368–741368. 10 indexed citations
3.
Zhang, Xiaobin, et al.. (2020). Neurotrophic factor changes are essential for predict electroconvulsive therapy outcome in schizophrenia. Schizophrenia Research. 218. 295–297. 6 indexed citations
4.
Gao, Ju, Xiaowei Tang, Congjie Wang, et al.. (2019). Aberrant cerebellar neural activity and cerebro-cerebellar functional connectivity involving executive dysfunction in schizophrenia with primary negative symptoms. Brain Imaging and Behavior. 14(3). 869–880. 17 indexed citations
5.
Zhou, Chao, Jiu Chen, Xiaowei Tang, et al.. (2018). DNA methylation and gene expression of the chemokine (C-X-C motif) ligand 1 in patients with deficit and non-deficit schizophrenia. Psychiatry Research. 268. 82–86. 13 indexed citations
6.
Ye, Fei, Xiaowei Tang, Jin Li, et al.. (2018). Altered serum levels of vascular endothelial growth factor in first-episode drug-naïve and chronic medicated schizophrenia. Psychiatry Research. 264. 361–365. 9 indexed citations
7.
Ye, Fei, et al.. (2018). Baseline serum vascular endothelial growth factor levels predict treatment response to antipsychotic medication in patients with schizophrenia. European Neuropsychopharmacology. 28(5). 603–609. 14 indexed citations
8.
Gao, Ju, Hongwei Yi, Xiaowei Tang, et al.. (2018). DNA Methylation and Gene Expression of Matrix Metalloproteinase 9 Gene in Deficit and Non-deficit Schizophrenia. Frontiers in Genetics. 9. 646–646. 27 indexed citations
9.
Ye, Fei, Chunlai Liu, Xiaowei Tang, et al.. (2017). Cognitive impairment in first-episode drug-naïve patients with schizophrenia: Relationships with serum concentrations of brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 76. 163–168. 38 indexed citations
10.
11.
12.
Sha, Weiwei, et al.. (2014). Relationship of serum testosterone levels with cognitive function in chronic antipsychotic-treated male patients with schizophrenia. Asia-Pacific Psychiatry. 7(3). 323–329. 10 indexed citations
13.
Zhang, Xiao‐Bin, Weiwei Sha, Xin Wang, et al.. (2013). Serum prolactin and smoking status in chronic antipsychotic-treated male patients with schizophrenia. Psychiatry Research. 209(2). 239–241. 2 indexed citations
14.
Zhang, Xiaobin, Xin Wang, Weiwei Sha, Honghui Zhou, & Yumei Zhang. (2011). Val66Met polymorphism and serum brain-derived neurotrophic factor concentration in depressed patients. Acta Neuropsychiatrica. 23(5). 229–234. 2 indexed citations
15.
Zhang, Xiaobin, Zhijun Zhang, Weiwei Sha, et al.. (2010). Effect of treatment on serum glial cell line-derived neurotrophic factor in bipolar patients. Journal of Affective Disorders. 126(1-2). 326–329. 40 indexed citations
16.
Sha, Weiwei, et al.. (2009). A prevalence study on domestic violence among married women in Yangzhou. Zhonghua xingwei yixue yu naokexue zazhi. 18(1). 60–62. 2 indexed citations
17.
Zhang, Xiaobin, Zhijun Zhang, Weiwei Sha, et al.. (2009). Electroconvulsive therapy increases glial cell-line derived neurotrophic factor (GDNF) serum levels in patients with drug-resistant depression. Psychiatry Research. 170(2-3). 273–275. 44 indexed citations
18.
Xie, Yun, Shaoxin Wang, Weiwei Sha, et al.. (2008). Effects and mechanism of glucagon-like peptide-1 on injury of rats cardiomyocytes induced by hypoxia-reoxygenation. Chinese Medical Journal. 121(21). 2134–2138. 23 indexed citations
19.
Zhang, Xiaobin, Zhijun Zhang, Chunming Xie, et al.. (2008). Effect of treatment on serum glial cell line-derived neurotrophic factor in depressed patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 32(3). 886–890. 72 indexed citations
20.
Zhang, Zhijun, Xiaobin Zhang, Gang Hou, Weiwei Sha, & Gavin P. Reynolds. (2002). The increased activity of plasma manganese superoxide dismutase in tardive dyskinesia is unrelated to the Ala-9Val polymorphism. Journal of Psychiatric Research. 36(5). 317–324. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wendy Shelly Breakdown of academic impact, for papers by Alexander Jatzko Breakdown of academic impact, for papers by Stephanie E. Daws Breakdown of academic impact, for papers by Chiyo Shibasaki Breakdown of academic impact, for papers by Anilkumar Pillai Breakdown of academic impact, for papers by Eiliv Brenner Breakdown of academic impact, for papers by Matthew Williams Breakdown of academic impact, for papers by Silvia Diekmann Breakdown of academic impact, for papers by Daniel T. Ohm
Rankless by CCL
2026